Prevalence of autoantibodies and the risk of autoimmune thyroid disease in children with chronic hepatitis C virus infection treated with interferon-alpha
about
Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progressionThe liver-cytokine-brain circuit in interferon-based treatment of patients with chronic viral hepatitis.Frequency of thyroid dysfunctions during interferon alpha treatment of single and combination therapy in hepatitis C virus-infected patients: a systematic review based analysisThyroid dysfunction in chinese patients with chronic hepatitis C treated with interferon alpha: incidence, long-term outcome and predictive factors.Managing pediatric hepatitis C: current and emerging treatment options.Study of non-organ-specific antibodies in children with genotype 4 chronic hepatitis C.Useful biomarkers for assessment of hepatitis C virus infection-associated autoimmune disorders.Autoimmunity and extrahepatic manifestations in treatment-naïve children with chronic hepatitis C virus infection.The prevalence of autoantibody and its relationship with genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection.Natural history of vertically acquired HCV infection and associated autoimmune phenomena.Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection.Hepatitis C virus infection in children and adolescents.
P2860
Q26773285-EC7E64F5-591D-434B-AB1C-9EFF9157BE10Q33962438-DA239D04-C8AC-4639-A352-6DABBD3BA1C8Q34577136-C74CD835-5ADD-4937-BEE8-4783D35B78A8Q36329350-62D01781-6AF2-4CD5-AE44-9AC0693E2667Q37316248-A527CF20-F701-4833-8EE2-5C1C1BAB4EABQ37645723-9ACC8925-BA33-4CB4-8FA6-F56A18F1CA8AQ37654478-C732CE18-1165-4FF3-993C-D769E1D2B315Q38014438-CFAF1835-AD71-4E3B-85B5-17DB107F4447Q40526929-1B2608E3-F0CA-422F-90F6-DB9B30DFF727Q42226319-48BAD8FC-290E-4C4B-B0FC-F039D157A419Q45401250-F134FA0A-D241-45A6-9060-720E4ED940FFQ54277218-0CC409EF-C14A-462E-9F4E-C2DF577AE0C8
P2860
Prevalence of autoantibodies and the risk of autoimmune thyroid disease in children with chronic hepatitis C virus infection treated with interferon-alpha
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Prevalence of autoantibodies a ...... treated with interferon-alpha
@ast
Prevalence of autoantibodies a ...... treated with interferon-alpha
@en
type
label
Prevalence of autoantibodies a ...... treated with interferon-alpha
@ast
Prevalence of autoantibodies a ...... treated with interferon-alpha
@en
prefLabel
Prevalence of autoantibodies a ...... treated with interferon-alpha
@ast
Prevalence of autoantibodies a ...... treated with interferon-alpha
@en
P2093
P2860
P356
P1476
Prevalence of autoantibodies a ...... treated with interferon-alpha
@en
P2093
Patrick Gerner
Philip Wintermeyer
Sabine Koeppelmann
Stefan Wirth
Stephan Gehring
Ulrike Kullmer
P2860
P304
P356
10.3748/WJG.V12.I36.5787
P407
P577
2006-09-01T00:00:00Z